Literature DB >> 18362358

MiR-15a and miR-16-1 cluster functions in human leukemia.

George A Calin1, Amelia Cimmino, Muller Fabbri, Manuela Ferracin, Sylwia E Wojcik, Masayoshi Shimizu, Cristian Taccioli, Nicola Zanesi, Ramiro Garzon, Rami I Aqeilan, Hansjuerg Alder, Stefano Volinia, Laura Rassenti, Xiuping Liu, Chang-Gong Liu, Thomas J Kipps, Massimo Negrini, Carlo M Croce.   

Abstract

MicroRNAs (miRNAs) are short noncoding RNAs regulating gene expression that play roles in human diseases, including cancer. Each miRNA is predicted to regulate hundreds of transcripts, but only few have experimental validation. In chronic lymphocytic leukemia (CLL), the most common adult human leukemia, miR-15a and miR-16-1 are lost or down-regulated in the majority of cases. After our previous work indicating a tumor suppressor function of miR-15a/16-1 by targeting the BCL2 oncogene, here, we produced a high-throughput profiling of genes modulated by miR-15a/16-1 in a leukemic cell line model (MEG-01) and in primary CLL samples. By combining experimental and bioinformatics data, we identified a miR-15a/16-1-gene signature in leukemic cells. Among the components of the miR-15a/16-1 signature, we observed a statistically significant enrichment in AU-rich elements (AREs). By examining the Gene Ontology (GO) database, a significant enrichment in cancer genes (such as MCL1, BCL2, ETS1, or JUN) that directly or indirectly affect apoptosis and cell cycle was found.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18362358      PMCID: PMC2278188          DOI: 10.1073/pnas.0800121105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Human genome: end of the beginning.

Authors:  Lincoln D Stein
Journal:  Nature       Date:  2004-10-21       Impact factor: 49.962

2.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

3.  Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses.

Authors:  S Kitada; J Andersen; S Akar; J M Zapata; S Takayama; S Krajewski; H G Wang; X Zhang; F Bullrich; C M Croce; K Rai; J Hines; J C Reed
Journal:  Blood       Date:  1998-05-01       Impact factor: 22.113

4.  Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.

Authors:  Aleksandar Petlickovski; Luca Laurenti; Xiaoping Li; Sara Marietti; Patrizia Chiusolo; Simona Sica; Giuseppe Leone; Dimitar G Efremov
Journal:  Blood       Date:  2005-02-22       Impact factor: 22.113

5.  Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals.

Authors:  Xiaohui Xie; Jun Lu; E J Kulbokas; Todd R Golub; Vamsi Mootha; Kerstin Lindblad-Toh; Eric S Lander; Manolis Kellis
Journal:  Nature       Date:  2005-02-27       Impact factor: 49.962

6.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.

Authors:  Lee P Lim; Nelson C Lau; Philip Garrett-Engele; Andrew Grimson; Janell M Schelter; John Castle; David P Bartel; Peter S Linsley; Jason M Johnson
Journal:  Nature       Date:  2005-01-30       Impact factor: 49.962

7.  Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice.

Authors:  Elizabeth S Raveche; Erica Salerno; Brian J Scaglione; Vijaya Manohar; Fatima Abbasi; Yi-Chu Lin; Torgny Fredrickson; Pablo Landgraf; Sumant Ramachandra; Konrad Huppi; Jorge R Toro; Vincent E Zenger; Robert A Metcalf; Gerald E Marti
Journal:  Blood       Date:  2007-03-09       Impact factor: 22.113

8.  Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia.

Authors:  James B Johnston; James T Paul; Nathan J Neufeld; Neil Haney; Dianne M Kropp; Xiaojie Hu; Mary Cheang; Spencer B Gibson
Journal:  Leuk Lymphoma       Date:  2004-10

9.  Investigation of microRNA alterations in leukemias and lymphomas.

Authors:  George Adrian Calin; Carlo Maria Croce
Journal:  Methods Enzymol       Date:  2007       Impact factor: 1.600

10.  ARED 3.0: the large and diverse AU-rich transcriptome.

Authors:  Tala Bakheet; Bryan R G Williams; Khalid S A Khabar
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

View more
  308 in total

1.  Pervasive and cooperative deadenylation of 3'UTRs by embryonic microRNA families.

Authors:  Edlyn Wu; Caroline Thivierge; Mathieu Flamand; Geraldine Mathonnet; Ajay A Vashisht; James Wohlschlegel; Marc R Fabian; Nahum Sonenberg; Thomas F Duchaine
Journal:  Mol Cell       Date:  2010-11-24       Impact factor: 17.970

Review 2.  Role of microRNAs in lymphoid biology and disease.

Authors:  Muller Fabbri; Carlo M Croce
Journal:  Curr Opin Hematol       Date:  2011-07       Impact factor: 3.284

3.  The microRNA 15a/16-1 cluster down-regulates protein repair isoaspartyl methyltransferase in hepatoma cells: implications for apoptosis regulation.

Authors:  Irene Sambri; Rosanna Capasso; Piero Pucci; Alessandra F Perna; Diego Ingrosso
Journal:  J Biol Chem       Date:  2011-10-27       Impact factor: 5.157

4.  The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2.

Authors:  Lisa E Young; Ashleigh E Moore; Lena Sokol; Nicole Meisner-Kober; Dan A Dixon
Journal:  Mol Cancer Res       Date:  2011-11-02       Impact factor: 5.852

5.  Identification of postoperative prognostic microRNA predictors in hepatocellular carcinoma.

Authors:  Ya-Hui Huang; Kwang-Huei Lin; Hua-Chien Chen; Ming-Ling Chang; Chao-Wei Hsu; Ming-Wei Lai; Tse-Ching Chen; Wei-Chen Lee; Yi-Hsin Tseng; Chau-Ting Yeh
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

6.  Targeting microRNAs with small molecules: from dream to reality.

Authors:  S Zhang; L Chen; E J Jung; G A Calin
Journal:  Clin Pharmacol Ther       Date:  2010-04-28       Impact factor: 6.875

Review 7.  Implication of microRNAs in drug resistance for designing novel cancer therapy.

Authors:  Fazlul H Sarkar; Yiwei Li; Zhiwei Wang; Dejuan Kong; Shadan Ali
Journal:  Drug Resist Updat       Date:  2010-03-17       Impact factor: 18.500

Review 8.  Molecular basis of CLL.

Authors:  Yuri Pekarsky; Nicola Zanesi; Carlo M Croce
Journal:  Semin Cancer Biol       Date:  2010-09-21       Impact factor: 15.707

9.  Alternatively expressed domains of AU-rich element RNA-binding protein 1 (AUF1) regulate RNA-binding affinity, RNA-induced protein oligomerization, and the local conformation of bound RNA ligands.

Authors:  Beth E Zucconi; Jeff D Ballin; Brandy Y Brewer; Christina R Ross; Jun Huang; Eric A Toth; Gerald M Wilson
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

10.  Recurrent reciprocal RNA chimera involving YPEL5 and PPP1CB in chronic lymphocytic leukemia.

Authors:  Thirunavukkarasu Velusamy; Nallasivam Palanisamy; Shanker Kalyana-Sundaram; Anagh Anant Sahasrabuddhe; Christopher A Maher; Daniel R Robinson; David W Bahler; Timothy T Cornell; Thomas E Wilson; Megan S Lim; Arul M Chinnaiyan; Kojo S J Elenitoba-Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.